Status:
UNKNOWN
The Role of Methylphenidate on Performance in the Cold
Lead Sponsor:
Brock University
Conditions:
Hypothermia
Exercise Test
Eligibility:
All Genders
18-55 years
Phase:
PHASE4
Brief Summary
The purpose is to study the effects of dopamine activity, using methylphenidate ingestion, on exercise and cognitive function over the course of a progressive cooling protocol. The investigators hypot...
Detailed Description
Temperature regulation and decision-making are vital aspects of human survival where relatively small deviations in whole-body heat balance lead to decrements in physical performance and cognitive fun...
Eligibility Criteria
Inclusion
- Males and females
Exclusion
- Diagnosed cardiovascular, respiratory, and/ or neuromuscular disease
- Prescription of MPH or any drugs for hyperactivity within the past 1 year
- Diagnosed mental health condition (e.g. depression, anxiety disorder)
- Raynaud's Disease or Cold Urticaria
- Current prescription medication (except for asthma or allergy medication)
- Pregnancy
Key Trial Info
Start Date :
December 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04283877
Start Date
December 15 2019
End Date
December 31 2021
Last Update
February 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Environmental Ergonomic Laboratory - Brock University
St. Catharines, Ontario, Canada, L2S 3A1